Evidence map›Paper›PMID 35516911›Full record

ArticleGeoHealth2022

Lower COVID-19 Incidence in Low-Continentality West-Coast Areas of Europe.

Karin Ebert, Renate Houts, Sergio Noce

Abstract read
In one paragraph

Article in GeoHealth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karin EbertNatural Sciences, Technology and Environmental Studies Södertörn University Stockholm Sweden.ORCID https://orcid.org/0000-0002-1030-5268
Renate HoutsDepartment of Psychology and Neuroscience Duke University Durham NC USA.ORCID https://orcid.org/0000-0002-1518-2631
Sergio NoceFondazione Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC) Division on Impacts on Agriculture, Forests and Ecosystem Services (IAFES) Viterbo Italy.ORCID https://orcid.org/0000-0002-6040-5638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In March 2020, the first known cases of COVID-19 occurred in Europe. Subsequently, the pandemic developed a seasonal pattern. The incidence of COVID-19 comprises spatial heterogeneity and seasonal variations, with lower and/or shorter peaks resulting in lower total incidence and higher and/or longer peaks resulting higher total incidence. The reason behind this phenomena is still unclear. Unraveling factors that explain why certain places have higher versus lower total COVID-19 incidence can help health decision makers understand and plan for future waves of the pandemic. We test whether differences in the total incidence of COVID-19 within five European countries (Norway, Sweden, Germany, Italy, and Spain), correlate with two environmental factors: the Köppen-Geiger climate zones and the Continentality Index, while statistically controlling for crowding. Our results show that during the first 16 months of the pandemic (March 2020 to July 2021), climate zones with larger annual differences in temperature and annually distributed precipitation show a higher total incidence than climate zones with smaller differences in temperature and dry seasons. This coincides with lower continentality values. Total incidence increases with continentality, up to a Continentality Index value of 19, where a peak is reached in the semicontinental zone. Low continentality (high oceanic influence) appears to be a strong suppressing factor for COVID-19 spread. The incidence in our study area is lowest at open low continentality west coast areas.

Indexed as

climate zonescontinentalityCOVID‐19 pandemicEuropean west‐wind zoneGIS

Identifiers

PMID35516911
PMCPMC9066745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.